Cargando…

HeartWare Thrombosis After mRNA COVID-19 Vaccination

Detalles Bibliográficos
Autores principales:	Schettle, Sarah, Frantz, Robert, Stulak, John, Villavicencio, Mauricio, Rosenbaum, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110650/ https://www.ncbi.nlm.nih.gov/pubmed/35787869 http://dx.doi.org/10.1016/j.mayocp.2022.05.010

Ejemplares similares

Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014)

Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
por: Gyoten, Takayuki, et al.
Publicado: (2020)

Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022)

Treatment of device thrombus in the HeartWare HVAD: surgical exchange through thoracotomy
por: Ghandour, Amale, et al.
Publicado: (2021)

Emergency HeartWare Ventricular Assist Device (HVAD) exchange due to pump thrombosis using minimally invasive technique
por: Antończyk, Remigiusz, et al.
Publicado: (2017)

Design Concepts and Preclinical Results of a Miniaturized HeartWare Platform: The MVAD System
por: Cheung, Anson, et al.
Publicado: (2015)

Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
por: Schramm, Rene, et al.
Publicado: (2020)

Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)

Flow dynamics during the HeartWare HVAD to HeartMate 3 exchange: A computational study assessing differential graft lengths and surgical techniques
por: Grinstein, Jonathan, et al.
Publicado: (2022)

Early thrombus formation in patient with HeartWare left ventricular assist device presenting with acute heart failure
por: Ucar, Mustafa, et al.
Publicado: (2016)

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device
por: Dang, Geetanjali, et al.
Publicado: (2014)

Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center
por: Esmaeilzadeh, Fatemeh, et al.
Publicado: (2016)

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Successful bridge to recovery using two-stage HeartWare LVAD explantation approach after embolic stroke
por: Sabashnikov, Anton, et al.
Publicado: (2013)

First successful percutaneous treatment of a totally occluded HeartWare outflow graft: Case report and literature review
por: Kemaloğlu, Cemal, et al.
Publicado: (2018)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis
por: Hinton, Jonathan, et al.
Publicado: (2021)

Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination
por: Atoui, Ali, et al.
Publicado: (2022)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population
por: Mahr, Claudius, et al.
Publicado: (2019)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Corticosteroids and mRNA Vaccines: A Word of Caution
por: Zhong, Zifu, et al.
Publicado: (2021)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis
por: Faissner, Simon, et al.
Publicado: (2021)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Painless thyroiditis following mRNA vaccination for COVID-19
por: Nakaizumi, Nobuhiko, et al.
Publicado: (2022)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

mRNA vaccination in children and youth: a cautionary note
por: Sergi, Consolato M.
Publicado: (2022)

Panuveitis following mRNA-based COVID-19 vaccine
por: Bouayad, A., et al.
Publicado: (2023)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
por: Francica, Alessandra, et al.
Publicado: (2023)

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
por: Carli, Giuseppe, et al.
Publicado: (2021)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Membranous nephropathy following anti–COVID-19 mRNA vaccination
por: Gueguen, Lorraine, et al.
Publicado: (2021)

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtqhl86ie4hu4105n6am5hb1mm